|
|
|
|
| LEADER |
02551nam a2200313 u 4500 |
| 001 |
EB002000522 |
| 003 |
EBX01000000000000001163423 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 130 |
0 |
|
|a Autism (National Collaborating Centre for Mental Health)
|
| 245 |
0 |
0 |
|a Autism
|h Elektronische Ressource
|b the management and support of children and young people on the autism spectrum
|c National Collaborating Centre for Mental Health ; commissioned by the National Institute for Health and Care Excellence
|
| 260 |
|
|
|a Leicester (UK)
|b The British Psychological Society and The Royal College of Psychiatrists
|c 2013, 2013 Aug
|
| 300 |
|
|
|a 1 PDF file (783 pages)
|b illustrations
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Child
|
| 653 |
|
|
|a Autism Spectrum Disorder / therapy
|
| 653 |
|
|
|a Evidence-Based Practice
|
| 653 |
|
|
|a Adolescent
|
| 710 |
2 |
|
|a National Collaborating Centre for Mental Health (Great Britain)
|
| 710 |
2 |
|
|a British Psychological Society
|
| 710 |
2 |
|
|a Royal College of Psychiatrists
|
| 710 |
2 |
|
|a National Institute for Health and Care Excellence (Great Britain)
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a NICE clinical guidelines
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK299062
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a This guideline has been developed to advise on the management and support of children and young people on the autism spectrum. The guideline recommendations have been developed by a multidisciplinary team of healthcare professionals, children and young people with autism, their carers and guideline methodologists after careful consideration of the best available evidence. It is intended that the guideline will be useful to clinicians and service commissioners in providing and planning high-quality care for children and young people with autism while also emphasising the importance of the experience of care for children and young people with autism and their carers. Although the evidence base is rapidly expanding, there are a number of major gaps. The guideline makes a number of research recommendations specifically to address gaps in the evidence base. In the meantime, it is hoped that the guideline will assist clinicians, and children and young people with autism and their carers, by identifying the merits of particular treatment approaches where the evidence from research and clinical experience exists
|